Intellectual Property India Publishes Patent Application for 'Engineered Varicella Zoster Virus Shingles Mrna Vaccine' Filed by Vernagen Llc

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517034828 A) filed by Vernagen Llc, Tucker, U.S.A., on April 9, for 'engineered varicella zoster virus shingles mrna vaccine.'

Inventor(s) include Kim Baek; Yoon Jack; and Pak David.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are a shingles vaccine composition including a messenger ribonucleic acid (mRNA) including an open reading frame (ORF) encoding varicella Zoster virus (VZV) glycoprotein E (gE)(which is soluble VZV gE or full length VZV gE) and a composition for inducing immune response against Shingles including the S...